v3.22.2.2
Condensed Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Revenue $ 816 $ 330 $ 3,617 $ 1,556 $ 2,772 $ 4,679
Cost of revenues 2,284 1,986 7,448 4,990    
Cost of revenue         7,101 6,695
Gross loss (1,468) (1,656) (3,831) (3,434) (4,329) (2,016)
Operating expenses:            
Research and development 488 327 1,340 978 1,450 1,330
Selling, general and administrative 2,367 1,154 6,223 2,508 4,844 4,103
Total operating expenses 2,855 1,481 7,563 3,486 6,294 5,433
Loss from operations (4,323) (3,137) (11,394) (6,920) (10,623) (7,449)
Other income (expense), net:            
Interest income and other, net           (5)
Interest income and other, net 79 (4) 118 (17)    
Gain on forgiveness of PPP loan     (24) 743 743 0
Other income (expense), net         (16) 36
Total other income (expense), net 79 (4) 118 726 727 31
Net loss $ (4,244) $ (3,141) $ (11,276) $ (6,194) $ (9,896) $ (7,418)
Weighted-average common shares outstanding:            
Weighted average shares outstanding, basic 69,013 65,772 66,859 65,762 65,764,502 [1] 65,693,821 [1]
Weighted average shares outstanding, diluted 69,013 65,772 66,859 65,762 65,764,502 [1] 65,693,821 [1]
Net loss per share of common stock:            
Basic net loss per ordinary share $ (0.06) $ (0.05) $ (0.17) $ (0.09) $ (0.15) [1] $ (0.11) [1]
Diluted net loss per ordinary share $ (0.06) $ (0.05) $ (0.17) $ (0.09) $ (0.15) [1] $ (0.11) [1]
[1] Restated for the retroactive application to reflect the effect of the Exchange Ratio established in the Business Combination as described in Note 1.